Boryung Pregabalin Capsule 25 mg

Adult dose

This medication is pregabalin, administered orally without regard to food in two divided doses per day. 1. Neuropathic Pain: 1) Peripheral Neuropathic Pain - Starting Dose: 150 mg per day - Titration: After 3 to 7 days, it can be increased to 300 mg per day, and if necessary, can be increased up to 600 mg at 7-day intervals. 2) Central Neuropathic Pain - Starting Dose: 150 mg per day

This medication is an anticonvulsant, and during treatment, suicidal thoughts or behaviors, emergence or worsening of depression, and unusual changes in mood or behavior must be carefully monitored. Patients with hypersensitivity to this medication or genetic lactose intolerance should not take it. Diabetic patients may need to adjust their blood sugar-lowering medication dosages due to weight gain. If symptoms of hypersensitivity, such as angioedema, occur, discontinue the medication immediately. Elderly patients should be cautious during initial dosing due to increased fall risk from dizziness and drowsiness. Vision changes or blurred vision may occur, but these symptoms may improve upon discontinuation of the medication. When switching to this medication as monotherapy, caution is advised due to insufficient data on the discontinuation of existing anticonvulsants. Withdrawal symptoms such as insomnia, headache, nausea, and anxiety can occur upon discontinuation, so it is advisable to taper off gradually. Patients with a history of drug abuse should be closely monitored as the risk of abuse may be higher with this medication. Dose adjustment may be necessary for patients with renal impairment, and there have been reports of improved renal function after discontinuation of the medication. Patients with heart disease should use this medication cautiously considering the risk of congestive heart failure. Caution is necessary when used in combination with opioid analgesics due to increased risk of central nervous system depression. Patients with respiratory or neurological diseases or the elderly are at heightened risk for severe respiratory depression and should have their doses adjusted. In early pregnancy, caution is advised due to the risk of fetal malformations, and effective contraception should be used in women of childbearing age. This medication may pass into breast milk, so breastfeeding should be discontinued or the medication considered for discontinuation. This medication can cause dizziness and drowsiness, so caution is needed before driving or operating dangerous machinery. Severe skin reactions may occur rarely, so if skin abnormalities appear, discontinue use and consult a healthcare professional immediately. In the event of overdose, symptoms such as altered consciousness, confusion, depression, and seizures may occur, necessitating immediate medical treatment. Keep out of reach of children, and it is safer not to change the container for storage.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, breathing difficulties accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme drowsiness, sudden and severe headache, thunderclap headache, seizures, altered consciousness, vision abnormalities, paralysis,

Mild side effects

• Dizziness
• drowsiness
• increased appetite
• loss of appetite
• hypoglycemia
• confusion
• loss of direction sense
• irritability
• depression
• euphoria

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. Recommended storage temperature is at room temperature between 15 to 30 degrees Celsius to maintain the drug's efficacy for a longer period.

Appearance

A hard capsule with a pale yellow upper part and a white lower part containing white or pale yellow powder

Package unit

30 capsules/bottle, 100 capsules/bottle